Educational Outcomes, Goals, and Objectives for
... Graduates of the program are empowered to treat and appropriately triage the most complex chronic and acute illnesses presented by emergency department patients, including those with multiple disease states and serious complications. They also acquire the experience necessary to exercise leadership ...
... Graduates of the program are empowered to treat and appropriately triage the most complex chronic and acute illnesses presented by emergency department patients, including those with multiple disease states and serious complications. They also acquire the experience necessary to exercise leadership ...
PRODUCT MONOGRAPH PrCELEBREX ® (celecoxib) Capsules
... uterine inertia (prolonged parturition) (see CONTRAINDICATIONS). ...
... uterine inertia (prolonged parturition) (see CONTRAINDICATIONS). ...
Seroquel - PI
... Although there are no data to specifically address re-initiation of treatment, it is recommended that when restarting therapy of patients who have been off SEROQUEL for more than one week, the initial dosing schedule should be followed. When restarting patients who have been off SEROQUEL for less th ...
... Although there are no data to specifically address re-initiation of treatment, it is recommended that when restarting therapy of patients who have been off SEROQUEL for more than one week, the initial dosing schedule should be followed. When restarting patients who have been off SEROQUEL for less th ...
... 10%), the results of the present study overlap with those of CARLSEN et al. [30], suggesting that children may benefit and obtain adequate clinical protection even from only 25 µg of inhaled salmeterol. Tachyphylaxis to the functional antagonism of salmeterol against EIA is an emerging problem. Rece ...
Wessex Pain Score - Portsmouth Hospitals NHS Trust
... Surgical Unit, (including Head and Neck), Orthopaedic Unit, Renal/Urology and Gynaecology Unit Paediatrics and Maternity. Referrals may be made by phone on extension 5890 or via bleep 1645/1643 or 1838. The Department of Pain Medicine, serves patients with chronic pain on an outpatient basis only (R ...
... Surgical Unit, (including Head and Neck), Orthopaedic Unit, Renal/Urology and Gynaecology Unit Paediatrics and Maternity. Referrals may be made by phone on extension 5890 or via bleep 1645/1643 or 1838. The Department of Pain Medicine, serves patients with chronic pain on an outpatient basis only (R ...
Product Monograph Template - Standard
... The safety and efficacy of AERIUS DUAL ACTION 12 HOUR has not been established in patients with impaired hepatic function, and there are insufficient data to give adequate dose recommendations. The combination product is not recommended for use in patients with impaired hepatic function (See ACTION ...
... The safety and efficacy of AERIUS DUAL ACTION 12 HOUR has not been established in patients with impaired hepatic function, and there are insufficient data to give adequate dose recommendations. The combination product is not recommended for use in patients with impaired hepatic function (See ACTION ...
File - Developing Anaesthesia
... Exact dosing and duration of dosing depends on the condition being treated as well as it severity. In general terms: ...
... Exact dosing and duration of dosing depends on the condition being treated as well as it severity. In general terms: ...
Misoprostol in obstetrics and gynecology
... physicians about drugs' indications, effectiveness, correct dosages, route of administration, dosage interval, contraindications, precautions, side-effects and management of complications. However, as misoprostol is generally not registered for reproductive health indications, the industry has neith ...
... physicians about drugs' indications, effectiveness, correct dosages, route of administration, dosage interval, contraindications, precautions, side-effects and management of complications. However, as misoprostol is generally not registered for reproductive health indications, the industry has neith ...
Efficacy and Safety of Traditional Medical Therapies for
... The articles were reviewed and the relevant data were abstracted to standard forms. Data extracted included (i) the therapy studied; (ii) the control agent; (iii) study design; (iv) number of patients; (v) mean age or age range; (vi) analysis by sex if available; (vii) duration of the study or cross ...
... The articles were reviewed and the relevant data were abstracted to standard forms. Data extracted included (i) the therapy studied; (ii) the control agent; (iii) study design; (iv) number of patients; (v) mean age or age range; (vi) analysis by sex if available; (vii) duration of the study or cross ...
LM - Prevalite Powder - Upsher
... In a large, placebo-controlled, multi-clinic study, LRC-CPPT1, hypercholesterolemic subjects treated with cholestyramine resin had mean reduction in total and low-density lipoprotein cholesterol (LDL-C) which exceeded those for diet and placebo treatment by 7.2% and 10.4%, respectively. Over the sev ...
... In a large, placebo-controlled, multi-clinic study, LRC-CPPT1, hypercholesterolemic subjects treated with cholestyramine resin had mean reduction in total and low-density lipoprotein cholesterol (LDL-C) which exceeded those for diet and placebo treatment by 7.2% and 10.4%, respectively. Over the sev ...
2
... in order to isolate and identify causative organisms and to determine their susceptibilities to vancomycin hydrochloride. The parenteral form of vancomycin hydrochloride may be administered orally for treatment of antibiotic-associated pseudomembranous colitis produced by C. difficile and for staphy ...
... in order to isolate and identify causative organisms and to determine their susceptibilities to vancomycin hydrochloride. The parenteral form of vancomycin hydrochloride may be administered orally for treatment of antibiotic-associated pseudomembranous colitis produced by C. difficile and for staphy ...
Full text in pdf format
... arthropods. Ingestion of high doses causes ovigerous American lobsters Homarus americanus to molt before their eggs hatch. To determine the effect of repeated exposure to doses at or below the noobserved-effect level (NOEL) of a single exposure (NOEL: 0.12 µg g–1), ovigerous lobsters were given eith ...
... arthropods. Ingestion of high doses causes ovigerous American lobsters Homarus americanus to molt before their eggs hatch. To determine the effect of repeated exposure to doses at or below the noobserved-effect level (NOEL) of a single exposure (NOEL: 0.12 µg g–1), ovigerous lobsters were given eith ...
... anti-inflammatory drugs that may lack clinically relevant systemic adverse reactions. This treatment, which is increasingly becoming a first-line treatment for asthma and rhinitis, is thought to reflect topical airway drug action [1]. However, a contribution from systemic anti-inflammatory action ca ...
evista - Eli Lilly Canada
... was most commonly reported during the first 6 months of treatment and infrequently was reported de novo after that time. Venous thromboembolism (VTE) and pulmonary embolism are uncommon but serious adverse events associated with raloxifene therapy. The greatest risk for deep vein thrombosis and pulm ...
... was most commonly reported during the first 6 months of treatment and infrequently was reported de novo after that time. Venous thromboembolism (VTE) and pulmonary embolism are uncommon but serious adverse events associated with raloxifene therapy. The greatest risk for deep vein thrombosis and pulm ...
- Nottingham ePrints
... tone (day 1) or light (day 2) was presented for 15 min. The time taken to make the first 50 licks in the absence of any stimulus (the A period) provided a measure of any individual variation in baseline lick responding. This was compared with the time taken to complete 50 licks following stimulus ons ...
... tone (day 1) or light (day 2) was presented for 15 min. The time taken to make the first 50 licks in the absence of any stimulus (the A period) provided a measure of any individual variation in baseline lick responding. This was compared with the time taken to complete 50 licks following stimulus ons ...
Morphine Sulphate Data sheet May 14
... morphine whenever adequate pain control can be achieved by this route. However, oral morphine is often inadequate or impractical in the terminally ill patient. Patients being converted from oral morphine to intravenous (IV) morphine require dosage reduction (about one-sixth), since about 60% of oral ...
... morphine whenever adequate pain control can be achieved by this route. However, oral morphine is often inadequate or impractical in the terminally ill patient. Patients being converted from oral morphine to intravenous (IV) morphine require dosage reduction (about one-sixth), since about 60% of oral ...
November 2016 Instructor`s Guide (MS Word format)
... a. Set up the game board (See Attachment 1) b. Review points system and how they are assigned to each drug category (See Attachment 2) c. Note: It is at the discretion of the instructor how much of an answer must be given to earn points. For example, if there are a list of adverse effects or contrai ...
... a. Set up the game board (See Attachment 1) b. Review points system and how they are assigned to each drug category (See Attachment 2) c. Note: It is at the discretion of the instructor how much of an answer must be given to earn points. For example, if there are a list of adverse effects or contrai ...
Leaflet PACKAGE LEAFLET: INFORMATION FOR THE
... Read all of this leaflet carefully before you start using this medicine. Keep this leaflet. You may need to read it again. If you have any further questions, ask your doctor or pharmacist. This medicine has been prescribed for you. Do not pass it on to others. It may harm them, even if their symptom ...
... Read all of this leaflet carefully before you start using this medicine. Keep this leaflet. You may need to read it again. If you have any further questions, ask your doctor or pharmacist. This medicine has been prescribed for you. Do not pass it on to others. It may harm them, even if their symptom ...
non-leukaemia related neutropenia or thrombocytopenia in the following
... performed weekly for the first month, biweekly for the second month, and periodically thereafter as clinically indicated (for example, every 2-3 months). In CML, the occurrence of these cytopenias is dependent on the stage of disease and is more frequent in patients with accelerated phase CML or bla ...
... performed weekly for the first month, biweekly for the second month, and periodically thereafter as clinically indicated (for example, every 2-3 months). In CML, the occurrence of these cytopenias is dependent on the stage of disease and is more frequent in patients with accelerated phase CML or bla ...
Imitrex - GlaxoSmithKline
... of these events have occurred in patients with no prior cardiac disease history and with documented absence of CAD, and the close proximity of the events to IMITREX® use support the conclusion that some of these cases were caused by the drug. In many cases, however, where there has been known underl ...
... of these events have occurred in patients with no prior cardiac disease history and with documented absence of CAD, and the close proximity of the events to IMITREX® use support the conclusion that some of these cases were caused by the drug. In many cases, however, where there has been known underl ...
Soluble guanylate cyclase stimulators as a potential
... the significant systemic effects, the possibility of an even further decrease in systemic pressures is not to be ignored if sGC stimulators are used in combination with PDE5 inhibitors. Inhaled sGC stimulators in combination with oral PDE5 inhibitors might be an attractive possibility [24]. Given th ...
... the significant systemic effects, the possibility of an even further decrease in systemic pressures is not to be ignored if sGC stimulators are used in combination with PDE5 inhibitors. Inhaled sGC stimulators in combination with oral PDE5 inhibitors might be an attractive possibility [24]. Given th ...
Abilify ® (Aripiprazole Tablets) - Bristol
... Rare cases of priapism have been reported with antipsychotic use such as ABILIFY. As with other psychotropic drugs, this adverse reaction did not appear to be dose-dependent and did not correlate with the duration of treatment. Hematologic In clinical trial and/or postmarketing experience, events of ...
... Rare cases of priapism have been reported with antipsychotic use such as ABILIFY. As with other psychotropic drugs, this adverse reaction did not appear to be dose-dependent and did not correlate with the duration of treatment. Hematologic In clinical trial and/or postmarketing experience, events of ...
ADHD drugs compared - Consumer Health Choices
... safe, effective medicines that give you the most value for your healthcare dollar. To learn more about the project and other drugs we’ve evaluated, go to www.CRBestBuyDrugs.org. We focus in this report on the use of ADHD drugs to treat children and teenagers age 17 and under. We also provide informa ...
... safe, effective medicines that give you the most value for your healthcare dollar. To learn more about the project and other drugs we’ve evaluated, go to www.CRBestBuyDrugs.org. We focus in this report on the use of ADHD drugs to treat children and teenagers age 17 and under. We also provide informa ...
Antiseizure drugs
... A group of chronic CNS disorders characterized by recurrent seizures. • Seizures are sudden, transitory, and uncontrolled episodes of brain dysfunction resulting from abnormal discharge of neuronal cells with associated motor, sensory or behavioral changes. ...
... A group of chronic CNS disorders characterized by recurrent seizures. • Seizures are sudden, transitory, and uncontrolled episodes of brain dysfunction resulting from abnormal discharge of neuronal cells with associated motor, sensory or behavioral changes. ...
Bad Pharma
.JPG?width=300)
Bad Pharma: How Drug Companies Mislead Doctors and Harm Patients is a book by British physician and academic Ben Goldacre about the pharmaceutical industry, its relationship with the medical profession, and the extent to which it controls academic research into its own products. The book was published in September 2012 in the UK by the Fourth Estate imprint of HarperCollins, and in February 2013 in the United States by Faber and Faber.Goldacre argues in the book that ""the whole edifice of medicine is broken"" because the evidence on which it is based is systematically distorted by the pharmaceutical industry. He writes that the industry finances most of the clinical trials into its own products and much of doctors' continuing education, that clinical trials are often conducted on small groups of unrepresentative subjects and negative data is routinely withheld, and that apparently independent academic papers may be planned and even ghostwritten by pharmaceutical companies or their contractors, without disclosure. Goldacre calls the situation a ""murderous disaster,"" and makes suggestions for action by patients' groups, physicians, academics and the industry itself.Responding to the book's publication, the Association of the British Pharmaceutical Industry issued a statement arguing that the examples the book offers are historical, that the concerns have been addressed, that the industry is among the most regulated in the world, and that it discloses all data in accordance with international standards.In January 2013 Goldacre joined the Cochrane Collaboration, British Medical Journal and others in setting up AllTrials, a campaign calling for the results of all past and current clinical trials to be reported. The British House of Commons Public Accounts Committee expressed concern in January 2014 that drug companies were still only publishing around 50 percent of clinical-trial results.